Home » Topics » Regulatory » Patents

Patents
RSS

Novel antihypertensives imparted by Novartis and NitroMed

Oct. 11, 2006

HIV reverse transcriptase inhibitors emerge from Roche R&D

Oct. 10, 2006

Recent patents report new treatments for depression, psychosis, sleep disorders, etc.

Oct. 10, 2006

Recent patents report novel treatment strategies for respiratory disorders

Oct. 10, 2006

New treatment options for cancer covered in recent patent literature

Oct. 9, 2006

Abbott patents novel RNA-directed RNA polymerase inhibitors

Oct. 9, 2006

Recent patents disclose novel antiinfective agents

Oct. 9, 2006

Recent patents impart new agents for atherosclerosis, hypertension, etc.

Oct. 6, 2006

Development of obestatin peptide derivatives reported by Leland Stanford Junior University

Oct. 6, 2006

Tokyo University of Science patent discloses novel agents for preventing transplant rejection

Oct. 6, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Investors bet on transformative BCI tech for neuro disorders
BioWorld
An estimated $2 billion has been invested in the brain-computer interface (BCI) space in the last two years and the level of funding is expected to continue....
Elixirgen and Nippon Shinyaku sign EXG-7001 option agreement
BioWorld Science
Elixirgen Therapeutics Inc. has entered into an option agreement with Nippon Shinyaku Co. Ltd. for the development and commercialization of EXG-7001 for Duchenne...